Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Taxes (2020 - 2025)

Universe Pharmaceuticals' Current Taxes history spans 6 years, with the latest figure at $640.8 million for Q3 2025.

  • On a quarterly basis, Current Taxes fell 37.25% to $640.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $640.8 million, a 37.25% decrease, with the full-year FY2025 number at $640.8 million, down 37.25% from a year prior.
  • Current Taxes hit $640.8 million in Q3 2025 for Universe Pharmaceuticals, down from $1.0 billion in the prior quarter.
  • Over the last five years, Current Taxes for UPC hit a ceiling of $1.0 billion in Q3 2024 and a floor of $434758.0 in Q3 2023.
  • Historically, Current Taxes has averaged $332.9 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Current Taxes: tumbled 54.25% in 2022 and later soared 234784.92% in 2024.
  • Tracing UPC's Current Taxes over 5 years: stood at $1.5 million in 2021, then tumbled by 54.25% to $694955.0 in 2022, then crashed by 37.44% to $434758.0 in 2023, then soared by 234784.92% to $1.0 billion in 2024, then tumbled by 37.25% to $640.8 million in 2025.
  • Business Quant data shows Current Taxes for UPC at $640.8 million in Q3 2025, $1.0 billion in Q3 2024, and $434758.0 in Q3 2023.